Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micafungin versus placebo in nosocomial sepsis among patients multi-colonized with Candida (EMPIRICUS)
2011-005451-14Phase 3Active
- Sponsor
- CHU Grenoble Alpes
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of micafungin in sepsis, candidiasis, sponsored by CHU Grenoble Alpes. Started Nov 2011; status: active.
02
Drugs
micafungin
03
Conditions
sepsiscandidiasis
Beyond the preview
Go deeper on 2011-005451-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005451-14.